COMBINATION OF ALPHA-2 RECEPTOR AGONIST (CLONIDINE) AND AN ANTI-MUSCARINIC AGENT (OXYBUTYNIN) FOR THE TREATMENT OF SIALORRHOEA
- 专利权人:
- ORIENT PHARMA (SAMOA) CO; LTD
- 发明人:
- ALAN GEOFFREY ROACH,PAUL GOLDSMITH
- 申请号：
- PT07705370
- 公开号：
- PT1986642E
- 申请日:
- 2007.02.12
- 申请国别(地区):
- PT
- 年份:
- 2014
- 代理人:
- 摘要：
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- COMBINATION OF ALPHA-2 RECEPTOR AGONIST (CLONIDINE) AND AN ANTI-MUSCARINIC AGENT (OXYBUTYNIN) FOR THE TREATMENT OF SIALORRHOEA
- Liquid formulation comprising an agonist of the alpha-2 receptors (eg, clonidine) and oxybutynin (antimuscarinic agent) for the treatment of sialorrhea
- COMBINATION OF ALPHA-2 RECEPTOR AGONIST (CLONIDIN) AND AN ANTI-MUSCARINIC AGENT (OXYBUTYNIN) FOR THE TREATMENT OF SIALORRHOEA
- LIQUID FORMULATION COMPRISING AN ALPHA-2 RECEPTOR AGONIST (E.G. CLONIDIN) AND OXYBUTYNIN (ANTI-MUSCARINIC AGENT) FOR THE TREATMENT OF SIALORRHOEA
- COMBINATION OF ALPHA-2 RECEPTOR AGONIST (CLONIDINE) AND ANTI-MUSCARINIC AGENT (OXYBUTYNIN) FOR TREATMENT OF SIALORRHOEA
